Bicara Therapeutics Inc.
BCAX
$9.32
-$0.11-1.17%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -5.65% | -5.96% | 155.46% | -11.54% | 0.00% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -32.23% | 1,596.03% | -65.98% | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -6.32% | -3.64% | 153.07% | -- | -- |
|
|
|||||
| Total Current Assets | -6.32% | -3.64% | 153.07% | -- | -- |
| Net Property, Plant & Equipment | -18.58% | 55.33% | -12.12% | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.26% | 212.91% | 1.29% | -- | -- |
| Total Assets | -6.26% | -2.70% | 151.06% | -- | -- |
|
|
|||||
| Total Accounts Payable | -39.22% | 129.77% | -58.10% | -- | -- |
| Total Accrued Expenses | 22.63% | 5.44% | 10.18% | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -2.64% | 97.08% | 2.67% | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 6.28% | 24.23% | -9.87% | -- | -- |
|
|
|||||
| Total Current Liabilities | 6.28% | 24.23% | -9.87% | -- | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -4.38% | -36.87% | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 5.51% | 23.96% | -10.23% | -- | -- |
|
|
|||||
| Common Stock & APIC | 0.55% | 0.46% | 8,995.28% | -- | -- |
| Retained Earnings | -16.67% | -10.48% | -9.57% | -- | -- |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -6.69% | -3.47% | 391.55% | -17.48% | 0.00% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | 0.00% | 0.00% |
|
|
|||||
| Total Common Equity | -6.69% | -3.47% | 391.55% | -17.48% | 0.00% |
| Total Preferred Equity | -- | -- | -- | 0.00% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -6.69% | -3.47% | 164.70% | -11.90% | 0.00% |
|
|
|||||